Zachary Petersen
Physician Assistant · Hill City, SDNPI 1568885952
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.5% of the total across 307 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 16.5% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in SD with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 307 payments — averaging $17.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$870
- Lilly USA, LLC$652
- Amgen$596
- Novartis$443
- Bayer$344
- Pfizer$289
- plus $2K from 18 others
What the payments were for
- Food & beverage$5,12897%
- Education$1343%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 53 | $870 |
| Lilly USA, LLC | 35 | $652 |
| Amgen | 37 | $596 |
| Novartis | 27 | $443 |
| Bayer | 13 | $344 |
| Pfizer | 17 | $289 |
| Boehringer Ingelheim | 15 | $257 |
| Sanofi-aventis U.S. LLC | 7 | $229 |
| Johnson & Johnson | 24 | $212 |
| Exact Sciences | 11 | $200 |
| AstraZeneca | 13 | $197 |
| GSK | 11 | $160 |
| AbbVie | 6 | $147 |
| Merck | 8 | $125 |
| E.r. Squibb & Sons, L.L.C. | 8 | $123 |
| Amarin Pharma, Inc. | 8 | $118 |
| Actelion Pharmaceuticals US, Inc. | 1 | $90 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $83 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
| Avanir Pharmaceuticals, Inc. | 2 | $30 |
| Pelvital USA, Inc. | 1 | $16 |
| Grifols USA, LLC | 1 | $16 |
| Eisai Inc. | 1 | $15 |
| Daiichi Sankyo Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RYBELSUS$125
- SOLIQUA 100/33$125
- Kerendia$125
- MOUNJARO$101
How this compares
$5,262 in reported general payments places this provider in the 95th percentile of 548 physician assistant providers in South Dakota.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Repatha SureclickEvolocumab | 73 | $101,585 |
| OzempicSemaglutide | 49 | $91,713 |
| EliquisApixaban | 38 | $48,169 |
| EntrestoSacubitril/Valsartan | 33 | $38,669 |
| MounjaroTirzepatide | 23 | $31,013 |
| JardianceEmpagliflozin | 23 | $28,390 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 17 | $24,374 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 15 | $23,590 |
| Praluent PenAlirocumab | 17 | $21,948 |
| FarxigaDapagliflozin Propanediol | 13 | $20,760 |
| Tresiba Flextouch U-200Insulin Degludec | 19 | $16,094 |
| Varenicline Tartrate | 18 | $9,192 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 13 | $5,980 |
| AbrysvoRsv Vacc, Pref A And Pref B/Pf | 14 | $4,549 |
| Atorvastatin Calcium | 412 | $3,910 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $870 | $91,71349 claims |
| PfizerEliquis, Abrysvo | $289 | $52,71952 claims |
| NovartisEntresto | $443 | $38,66933 claims |
| Boehringer IngelheimJardiance, Stiolto Respimat | $257 | $34,37036 claims |
| Lilly USA, LLCMounjaro | $652 | $31,01323 claims |
| GSKTrelegy Ellipta | $160 | $23,59015 claims |
| AstraZenecaFarxiga | $197 | $20,76013 claims |
| AbbVieSynthroid | $147 | $1,30627 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 548 physician assistant providers in South Dakota.
Other physician assistant in Hill City
- Desirae DiniusHill City$3K
- Kimberly NelsonSioux Falls$11K
- Jordan HeinsRapid City$10K
- Ryanne WaageAberdeen$9K
- Christina PekoskeSioux Falls$9K
- Rachel HotvetSioux Falls$8K
- Jarrett FowlerRapid City$7K
- Jerome WenningerRapid City$7K
- Alyssa MrsnyDakota Dunes$7K
- Gabriel PenaredondoSioux Falls$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.